A

Aptevo Therapeutics
D

APVO

4.70500
USD
0.10
(2.06%)
مغلق
حجم التداول
1,167
الربح لكل سهم
-38
العائد الربحي
-
P/E
-0
حجم السوق
6,861,974
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADMA
    0.100
    (0.61%)
    16.580 USD
    A
    APLT
    -0.01020
    (-1.62%)
    0.61980 USD
    A
    ASND
    1.170
    (0.93%)
    127.320 USD
    K
    KURA
    0.36500
    (4.65%)
    8.22000 USD
    L
    LGND
    -0.560
    (-0.48%)
    115.130 USD
    M
    MRKR
    0.16000
    (7.37%)
    2.33000 USD
    O
    OCUL
    -0.01000
    (-0.13%)
    7.98000 USD
    R
    RIGL
    0.290
    (1.33%)
    22.120 USD
    المزيد
الأخبار
المقالات

العنوان: Aptevo Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.